Skip to main content
Clinical Trials/CTRI/2023/10/059156
CTRI/2023/10/059156
Not yet recruiting
Phase 2

Camparison of the efficacy of the combination of the Oxytocin and Rectal Misoprostol (600mcg) with Oxytocin alone for active manaegment of third stage labour following singleton vaginal delivery - A randomised, double binded, placebo-controlled trial (OxyPGE1 Trial) - OxyPGE1 Trial

Intramural Jawarharlal Institute of Postgraduate Medical Education and Research0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Intramural Jawarharlal Institute of Postgraduate Medical Education and Research
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Intramural Jawarharlal Institute of Postgraduate Medical Education and Research

Eligibility Criteria

Inclusion Criteria

  • 1\. Pregnant women \= 18 years of age
  • 2\. Gestational age \=37 weeks to 42 weeks
  • 3\. Following singleton vaginal delivery

Exclusion Criteria

  • 1\. Antepartum haemorrhage
  • 2\. Pre\-existing bleeding disorders
  • 3\. Fever ( \>38?C)
  • 4\. Acute Gastroenteritis
  • 5\. Known hypersensitivity to Oxytocin or Misoprostol
  • 6\. Distressed due to labour pains to give informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials